Jantine van Voorden

Ms. Jantine van Voorden

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JVJantine van Voorden
Jantine van Voorden
RKRemco Keijser
Remco Keijser
GVGeertruda J. M. Veenboer
Geertruda J. M. Veenboer
SCSolange A. Lopes Cardozo
Solange A. Lopes Cardozo
DDDina Diek
Dina Diek
GAGijs Afink
Gijs Afink
Early placenta development involves cytotrophoblast differentiation into extravillous trophoblast (EVT) and syncytiotrophoblast (STB). Defective trophoblast development and function may result in severe pregnancy complications, including fetal growth restriction and pre-eclampsia. The incidence of these complications is increased in pregnancies of fetuses affected by Rubinstein–Taybi syndrome, a developmental disorder predominantly caused by heterozygous mutations in CREB-binding protein ( CREBBP ) or E1A-binding protein p300 ( EP300 ). Although the acetyltransferases CREBBP and EP300 are paralogs with many overlapping functions, the increased incidence of pregnancy complications is specific for EP300 mutations. We hypothesized that these complications have their origin in early placentation and that EP300 is involved in that process. Therefore, we investigated the role of EP300 and CREBBP in trophoblast differentiation, using human trophoblast stem cells (TSCs) and trophoblast organoids. We found that pharmacological CREBBP/EP300 inhibition blocks differentiation of TSCs into both EVT and STB lineages, and results in an expansion of TSC-like cells under differentiation-inducing conditions. Specific targeting by RNA interference or CRISPR/Cas9-mediated mutagenesis demonstrated that knockdown of EP300 but not CREBBP, inhibits trophoblast differentiation, consistent with the complications seen in Rubinstein–Taybi syndrome pregnancies. By transcriptome sequencing, we identified transforming growth factor alpha (TGFA, encoding TGF-α) as being strongly upregulated upon EP300 knockdown. Moreover, supplementing differentiation medium with TGF-α, which is a ligand for the epidermal growth factor receptor (EGFR), likewise affected trophoblast differentiation and resulted in increased TSC-like cell proliferation. These findings suggest that EP300 facilitates trophoblast differentiation by interfering with at least EGFR signaling, pointing towards a crucial role for EP300 in early human placentation.

Verified
Journal Article
Open access
PDF file
JVJantine van Voorden
Jantine van Voorden
SBSouad Boussata
Souad Boussata
RKRemco Keijser
Remco Keijser
MVMarloes Vermij
Marloes Vermij
MWMuriel Wagner
Muriel Wagner
GAGijs Afink
Gijs Afink
Placentation disorders, including severe preeclampsia and fetal growth restriction, have their origins in early pregnancy, whereas symptoms typically present later on. To investigate the pathogenesis of these diseases, there is a need for a reliable in vitro model system of early placenta development with known pregnancy outcomes. Therefore, we optimized the generation of human induced trophoblast stem cells (iTSCs) from term umbilical cord, enabling non-invasive collection of patient-derived material immediately after birth. Using a direct reprogramming approach previously described for dermal fibroblasts, we investigated the effects of three supplements (A-485, BMP4, and EPZ-6438) to assess their potential to enhance iTSC induction. The generated iTSCs fulfilled the criteria for bona fide first-trimester trophoblasts and exhibited key functional capacities, including long-term self-renewal, differentiation into hormone-producing syncytiotrophoblasts and invasive extravillous trophoblasts, and the formation of organoids. Furthermore, transcriptomic analysis revealed high similarity between the generated iTSCs and trophoblast stem cells derived from first-trimester placental tissue. The supplements did not improve the generation of iTSCs. In conclusion, we successfully generated bona fide iTSCs from term umbilical cord using a direct reprogramming approach, providing a robust and clinically relevant model to study early placentation mechanisms in patient-derived trophoblasts.

20 June 2026 in iScience
Verified
Journal Article
Open access
JVJantine van Voorden
Jantine van Voorden
FLFangxu Lin
Fangxu Lin
SBSouad Boussata
Souad Boussata
RKRemco Keijser
Remco Keijser
LBLiana Barenbrug
Liana Barenbrug
GAGijs Afink
Gijs Afink
Proper placental development requires extravillous trophoblast (EVT) differentiation and invasion into the maternal decidua to remodel spiral arteries and support fetal growth. Disruptions in these processes contribute to preeclampsia and fetal growth restriction. These pregnancy complications are common in women with immune-mediated inflammatory diseases, which are characterized by elevated levels of pro-inflammatory cytokines such as interferon-α (IFN-α) and tumor necrosis factor-α (TNF-α). However, the direct effects of these cytokines on EVTs remain unclear. Using human trophoblast organoid models, we demonstrate that IFN-α and TNF-α impair EVT invasion while preserving differentiation capacity. High-resolution imaging of untreated organoid-decidua co-cultures revealed extensive trophoblast invasion into decidual stroma and arteries, but invasion was substantially reduced particularly upon IFN-α treatment. Transcriptome profiling identified changes in several invasion-related pathways after cytokine exposure. These findings suggest that elevated IFN-α and TNF-α can directly impair trophoblast invasive capacity, potentially contributing to suboptimal placental development in inflammatory disorders.

20 August 2025 in bioRxiv
Verified
Preprint
Open access
JVJantine van Voorden
Jantine van Voorden
FLFangxu Lin
Fangxu Lin
SBSouad Boussata
Souad Boussata
RKRemco Keijser
Remco Keijser
LBLiana Barenbrug
Liana Barenbrug
GAGijs Afink
Gijs Afink
Proper placental development requires differentiation and invasion of extravillous trophoblasts (EVTs) into the maternal decidua to ensure adequate remodeling of spiral arteries and support fetal growth. Perturbations in these processes are associated with pregnancy complications such as preeclampsia and fetal growth restriction. The incidence of these pregnancy complications is increased in women with immune-mediated inflammatory diseases, which are characterized by elevated levels of pro-inflammatory cytokines, such as interferon alpha (IFN-α) and tumor necrosis factor alpha (TNF-α). However, the direct effects of these cytokines on trophoblast differentiation and invasion remain unclear. Using human trophoblast organoid models, we demonstrate that IFN-α and TNF-α impair EVT invasion while preserving their differentiation capacity. High-resolution imaging of untreated organoid–decidua co-cultures revealed extensive invasion of organoid-derived trophoblasts into the decidual stroma and spiral arteries. In contrast, organoids treated with IFN-α, in particular, exhibited markedly reduced invasion within this system. Transcriptome profiling indicated altered expression of several pathways involved in invasion upon cytokine treatment. These findings support the notion that elevated levels of IFN-α and TNF-α can directly impair trophoblast invasive capacity, potentially contributing to suboptimal placental development and adverse pregnancy outcomes in the context of inflammatory disorders.